Future Science Group

In the first installment of this two-part episode with Donald Ingber, Founding Director of the Wyss Institute (MA, USA), we discuss his invention of organ-on-a-chip technology, how he is utilizing them in the fight against COVID-19 and the Wyss Institute's response to the pandemic. Donald touches on the performance of the much-discussed chloroquine in his lung-on-a-chip models. We also discuss the...

In this episode BioTechniques Digital Editor, Tristan Free speaks to Annie Evans, Director of R&D and David Foster, Vice President of Data and Informatics at Metabolon about the latest developments in microbiome studies, including big data analysis, LCMS, alpha diversity and at-home fecal sample collection.

In this episode BioTechniques Digital Editor, Tristan Free, speaks to Paul Brennan, President and CEO of NervGen, about the company's new technique, currently under development, for repairing nerve damage and it's potential for treating Alzheimer's. Paul also covers some of the gaps in Alzheimer's research and wades in on the Tau vs Amyloid Beta debate.

Talking at ASCB 2019 in Washington, Andrea Brand, Head of the Gurdon Institute's Wellcome labs, and BioTechniques Digital Editor Tristan Free, discuss Andrea's work in neural stem cells and brain cancers. Andrea's novel technique for analyzing proteins binding throughout the genome, TADA, which can be employed in live animals, is also explored alongside the integration of genetic and imaging techn...

Hello, and welcome to this episode of OC talks Podcast Series brought to you by Oncology Central. I am Jade Parker, Senior Editor of Oncology Central, a free online platform that unites all aspects of oncology to support a multidisciplinary approach to progression of the field. In this episode today, we will be speaking to Wout Brusselaers from Deep6 AI about how artificial intelligence (AI) is ch...

Digital Editor Tristan Free and Digital Intern Theo Kemp, speak to Stephen Taylor of The MRC Weatherall Institute of Molecular Medicine. Stephen discusses his work in developing novel systems to interpret biomedical data sets and CSyth; the visualization program for DNA folding.

The vitality of vital statistics: an interview with Alan Lopez by Taylor & Francis Group

Editor Jennifer Straiton speaks to the winner of the 2019 Future Science Future Star Award, Marjorie Pizarro-Guajardo. Marjorie is a postdoctoral fellow at the Universidad Andrés Bello (Chile) specializing in microbiology. Her work focuses on the development of a strategy to remove Clostridium difficile spores from the host to make a therapy that can improve the clearance of the infection.

Welcome to this episode of OC Talks Podcast Series brought to you by Oncology Central. In this episode today of OC talks we will be speaking to Nandita deSouza from the Institute of Cancer Research and the Royal Marsden Hospital (both London, UK) to discuss the Cancer Research UK funded DISCOVAR trial.

Rob Knight speaks to BioTechniques Managing Editor, Joseph Martin, about the upcoming BioTechniques Online Event: Advancing Precision Medicine 2019, his scientific hero and gives advice for early career researchers.

In this podcast, Jason Causon (Technical Product Manager at SCIEX, Canada) discusses his experience with HRMS and the current research focuses at SCIEX. He also details how SCIEX are using HRMS, the biggest challenges that have had to be overcome and future opportunities that he hopes HRMS software will bring.

In this podcast, Mark Wrona (Principal Scientist at Waters Corporation; MA, USA) discusses his experience with HRMS and the current trends in the field of drug metabolism and pharmacokinetics (DMPK). He discusses the role HRMS plays in the analysis of biopharmaceuticals and compares the advantages of HRMS compared to triple quad.

Szabolcs Szarka (LGC) discusses the challenges, benefits and what the future may hold for HRMS in this podcast, exclusive to the Bioanalysis Zone Spotlight on HRMS in DMPK. You can find many more resources on HRMS via the HRMS in DMPK Spotlight pages on Bioanalysis Zone.

Hans Kierstead, CEO and founder of Aivita Biomedical, Speaks to Tristan Free, Digital Editor of BioTechniqes. Hans delves into his company's exciting new precision immunotherapy, currently undergoing phase II trials and discusses his 2018 run for US Congress, explaining why he is passionate about the need for scientists in politics.

In this podcast, senior scientists from Alturas Analytics (ID, USA), Katherine Yahvah, Chad Christianson and Michael Williams discuss some of the challenges they have faced and some of the solutions they have successfully implemented.

Joanne Hackett, Chief Commercial Officer at Genomics England, discusses their goals, completing major milestones in genomics research and approaching precision medicine.

Jade Parker, Senior Editor of Oncology Central is joined by Patrick Connor from AstraZeneca to discuss the Lung Ambition Alliance to find out how the Lung Ambition Alliance is looking to one day eliminate lung cancer as a cause of death and double the 5-year survival rate for the disease by 2025. Date of preparation: July 2019 Date of expiry: July 2020 Document ID: Z4-18671

In this interview, we talk to Mary Lame, Principal Applications Scientist who supports discovery bioanalysis for both large and small molecules, providing application development and support with Waters Corporation (Milford, MA, USA). Mary will discuss the key challenges scientists face developing robust peptide bioanalytical assays and introduces Waters approach for large molecule bioanalytical q...

Georgi Makin, Editor of 3DMedNet, is joined by Jacob Koffler (University of California San Diego; CA, USA) as they discuss how 3D printing is being used in spinal cord injury research. As part of 3DMedNet’s special feature - 3D in focus: applications in neuro R&D – Georgi and Jacob explore 3D printing in neurology and neuroscience. Find out more: Georgi Makin is the Editor of 3DMedNet (www.3dmedne...

BioTechniques Digital and Assistant Editors Abigail Sawyer and Tristan Free talk to Greg Mitchelotti of Metabolon about metabolomics, its potential applications in precision medicine and the new $4 million research collaboration with the Canadian Longitudinal Study of Aging and other Canadian institutions to identify biomarkers for frailty.

In this interview, hear from Catharina Brandsten, Head of Tissue Establishment and Kristina Runeberg, Site Head, at Takara Bio Europe, about deriving ethical and GMP-grade embryonic stem cells.

Hear more about the recent mass spectrometry product launches from SCIEX announced at ASMS 2019, including the new Acoustic Ejection Mass Spectrometry technology, in this interview with Neil Walsh (SCIEX; MA, USA).

Understanding automation in cell therapy manufacturing: an interview with Markus Gershater by Taylor & Francis Group

BioTechniques Digital and Assistant Editors Abigail Sawyer and Tristan Free talk to Theo Roth from the University of California San Francisco Marson Lab (CA, USA). Having recently made headlines for his work in T-cell engineering, Theo takes us through his groundbreaking CRISPR research, its potential impacts in CAR-T cell therapy and further afield, whilst also tackling the evolving ethics in gen...

In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.